6-precursor acute lymphoblastic leukemia bone marrow specimens that contained subpopulations of cells with immunophenotypes corresponding to early (CD34) and late (CD20) and (CD22) stages of normal B-cell differentiation were studied. Subpopulations of cells were isolated according to immunophenotype and then analyzed by both a clonogenic assay and molecular genetic methods. Clonal equivalence of the early and late immunophenotypic subpopulations was confirmed for each case by the demonstration of identical lg gene rearrangements. The in vitro colony-forming assay consistently showed a growth advantage for the CD34' -PRECURSOR acute lymphoblastic leukemia (ALL), B the most common form of leukemia in children, is presumed to result from a series of leukemogenic events that occur in a single progenitor cell and, possibly, in its monoclonal progeny. The monoclonality is convincingly demonstrated by a specific rearrangement of the Ig heavy chain (IgH) gene, which serves as a clonal marker for each individual case of the leukemia.'!' The immunophenotypes of B-precursor ALL cells, although often aberrant, resemble stages of normal B-cell de~elopment.~ B-cell maturation is characterized by the sequential appearance of differentiation antigens, which are detected by known monoclonal antibodies (MoAbs)?
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Immunophenotypic heterogeneity is observed when the whole leukemia cell population of an individual patient is examined for differentiation antigen expression?. 6 This heterogeneity may reflect the existence of a subpopulation of disease-sustaining cells with self-renewal capability and subpopulations of effete, benign progeny that are committed to a differentiation program. The subpopulation of cells with self-renewal capability is the appropriate target of curative treatment. Demonstration of differentiation within B-precursor ALL could lead to the identification of the disease sustaining cells and is, therefore, of importance for both the understanding of the disease process and the design of more effective treatment methods.
In normal lymphopoiesis the hematopoietic progenitor cell antigen, CD34, appears only on the earliest cells of the B-lineage, while the CD20 and CD22 antigens appear at intermediate and late stages, re~pectively.~ Because these surface markers are frequently observed on B-precursor ALL cells, we sought to determine whether maturation, described by the B-cell differentiation antigens, could be detected in B-precursor ALL. To accomplish this, we compared biologic and molecular properties of isolated leukemia cell subpopulations characterized by the CD34 antigen with those characterized by the CD20 and CD22 antigens. The results of this comparison show that these differentiation antigens define a limited program of differentiation in this leukemia that preserves the features of normal B-cell development. As far as we know, this is the first demonstration, supported by measurements of growth subpopulations over the CD34-subpopulations. CD34 mRNA was detected readily in these isolated precursor cells. When two specimens in which virtually all of the leukemia cells were CD34' and CD34+CD20' and CD34+CD22+ subpopulations were also present the CD34 mRNA was limited to the cells without the late-stage differentiation antigens on their surface. Furthermore, the c-myb mRNA was found only in the subpopulations that also contained CD34 mRNA. Our results show that a limited program of differentiation reminiscent of normal B-cell development may be present in this leukemia.
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tems, Westwood, MA) modified as previously described."' These studies were restricted to B-precursor ALL cell populations that consisted of greater than 90% HLA-DR+CD19+ cells and also contained a subpopulation of CD34+ cells."
For three specimens, the subpopulations were isolated by hoth fluorescence-activated cell sorting and magnetic bead separation as described by Spangrude et aL'* Because the results of the two methods were not significantly different, the remainder of the specimens were separated by the magnetic bead technique, which required less time. For this separation method, cells were incubated with the primary unconjugated MoAb at 4°C for 30 minutes, washed, and then incubated for 30 minutes with goat antimouse IgG covalently attached to 1 pm paramagnetic beads (Advanced Magnetics, Cambridge, MA). The magnetic bead-coated cells (positive fraction) were retained by a magnet while the unstained cells (negative fraction) remained in the supernatant.
The purity of the positive fraction was determined by staining with fluorescein isothiocyanate-conjugated goat antimouse IgG (Caltag, South San Francisco, CA), followed by immunofluorescence analysis. The purity of this fraction was routinely greater than 98%. Negative fractions with purity between 90% and 95% were obtained by a second incubation with MoAb and magnetic beads followed by magnetic separation. The purity of the subpopulations sorted by flow cytometry was at least 90%. The viability of the sorted cells was always greater than 95% by trypan blue exclusion. T-cell contamination was determined by staining with an anti-Leu1 (CD5), anti-leu4 (CD3), and anti-Leu9 (CD7) MoAb mixture (Becton Dickinson) followed by immunofluorescence analysis. When T-cell contamination exceeded 1%, the cells were incubated with the anti-T-cell MoAb mixture and removed by magnetic bead separation.
Southem blot una&sis. High molecular weight DNA was extracted from isolated subpopulations by the method of Hanson The blast colony assay has been described in detail previo~sly.'~~'~ In brief, 1 X 10s ALL cells were suspended in a-medium, 10% fetal calf serum, 10% phytohemaglutinin-T-cell-conditioned medium, and methylcellulose at a final concentration of 0.9%. Cells were plated in the presence of 105 irradiated feeder cells in 35-mm Petri dishes. Feeder cells were normal donor peripheral blood depleted of adherent cells, incubated for 2 hours at 37"C, quickly cooled to O' C, and exposed to 70 Gy of y irradiation. The culture dishes were placed in an incubator Subpopulation isolation.
ALL blast colony assay.
at 37°C with a humidified atmosphere of 5% CO, and balanced nitrogen. Colonies were counted on days 6 and 10 of incubation, and a cluster of greater than 20 cells defined as a colony. Total cellular RNA from about 5 x lo6 cells was recovered by the acid-guanidinium-phenol-chloroform extraction method.'' Three micrograms of RNA (as determined by optical density at 260 nm) per lane was electrophoretically fractionated in 1.25% agarose gels containing f~rmaldehyde.'~ Transfer to nitrocellulose membranes (BioRad, Richmond, CA), baking, hybridization, and washes were done as described elsewhere.m Membranes were exposed to x-ray film with two intensifying screens. 32P-labeled probes were prepared by the randomprimed labeling method:' purified by Sephadex G-50 (Pharmacia) chromatography, ethanol precipitated with salmon sperm carrier DNA, and resuspended in water before use in Northern blot analysis. The CD34 probe was a gift from Dr Brian Seed (Massachusetts General Hospital, Boston, MA) and the c-myb probe was obtained from the ATCC.
Northem blot hybridization.

RESULTS
Subpopulations defined by the CD34, CD20, and CD22 surface antigens have identical IgH gene rearrangements.
The characteristics of the patients and the laboratory data obtained at diagnosis are presented in Table 1 . Three-color immunofluorescence studies confirmed that in all seven cases there was a distinct CD34'CD19+HLA-DR'CDlO' subpopulation that was negative for the CD20 and CD22
antigens. In two of the cases, greater than 90% of the leukemia cells were CD34' with subpopulations that simultaneously bore the CD20 and CD22 antigens on their surfaces. These results are in agreement with previous studies which indicate that immunophenotypic subpopulations corresponding to the early and late stages of normal B-cell differentiation are present in B-precursor ALL.5s6
The status of the IgH gene rearrangement, the clonal marker for the leukemia, was then examined by Southern analysis using the J, probe for isolated subpopulations corresponding to early and late stages of normal B-cell differentiation. The subpopulation corresponding to the early stage of development consisted of CD34' cells that did not express either the CD20 or the CD22 antigens. The other subpopulations either lacked CD34 or were positive for one of the late B-cell differentiation antigens, CD20 and CD22. In all seven cases the gene rearrangement band obtained for the two isolated subpopulations were identical, indicating that both subpopulations of leukemia cells For for thc CD34-cclls. Thc avcragc overall plating cfficicncy. mcasurcd at 6 days, was 1.5 x in agrccmcnt with prcvious rcsults using this a~say.'~'''''~?" The cclls from thc colonics had lymphoid morphology whcn WrightGiemsa stained preparations wcrc cxamincd. Cytochemical studies showed that they wcrc pcriodic acid Schiff positive but myclopcroxidasc and nonspccific cstcrasc ncgativc. Marrow from hcalthy donors cultured undcr idcntical conditions did not dcvclop colonics with the charactcristics of thc lcukcmia cell colonics at days 5 to 7.
CD34 mfWA is mostly in sidppidations with pqenitor immunophenotype. Samples from paticnts 6 and 7 are typical cxamplcs of thc simultancous appcarancc of early and latc diffcrcntiation antigcns on thc lcukemia cell surfacc. Grcatcr than 90% of the lcukcmia cells of these two paticnts wcrc CD34*, with subpopulations that also cxprcsscd cithcr thc CD20 or CD22 antigcns. Figure 2a shows thc rcsults of the immunofluorcsccncc analysis of the cclls from patient 7 labclcd with thc anti-CD-34 and wcrc mcmbcrs of thc same clone. Typical results of this analysis arc shown in Fig 1. CD34' leukemia cel1.s have a p w t h advantage when compared with CD34-leukemia celk. To determine whether the diffcrcnccs in immunophcnotype wcrc accompanied by diffcrcnccs in biologic activity, leukemia cclls from fresh bone marrow spccimcns of paticnts 1 through 4 wcrc separated into CD34' and CD34-subpopulations and the growth of thc two groups compared using thc in vitro ALL blast colony assay. Thc rcsults of thc ALL blast colony assay arc prcscntcd in Table 2 . Whcn lo' cclls wcrc plated for each subpopulation. the CD34' leukemia cclls consistcntly formed a grcatcr number of colonics than did thc CD34-lcukcmiacclls(P = .O117, Wilcoxon sign rank tcst). Furthcrmorc, the CD34' colonies rcmaincd viable for at lcast IO days, whcrcas thc CD34-colonics dctcrioratcd after 7 days.
The number of colonics per plated cell ranged from 4. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From antLCD20 MoAbs. We compared CD34 mRNA levels in cells from the fresh bone marrow specimen sorted according to the prcscnce or absence of these later appearing antigens to determine whether the CD34 gene is active in both the CD34TD20-and the CD34TD20' B-precursor ALL cells. Total cellular RNA was isolated from the sorted cells and analyzed. The distinct 28s and 18s bands Seen in the ethidium bromide stained gel (Fig 2b. lanes4 through 6) show that the sorting procedure did not significantly affect RNA integrity. Howcvcr, the spreading of the 28s band in lane 5 illustrates the consistent finding, in thcsc studies, that the RNA isolated from subpopulations Characterized by the late-stage differentiation antigens was both less in amount and lower in integrity when compared to that from subpopulations with precursor immunophenotypc. This result was unaffccted by either isolation of the same subpopulation by positive rather than negative selection or diffcrcnccs in the total time to recover the RNA after the spccimcn was drawn. The results of Northern blot hybridization (Fig 2c, lanes 4 through 6) indicated that by far the greatest portion of the CD.34 mRNA was present in the CDM'CD20-subpopulation (lane 6). although a vety weak band was observed in the CD34'CD20' subpopulation (lane 5). CD34 mRNA was not detected in an identical amount of RNA recovered from the mononuclear fraction of normal bone marrow cells in which there were approximately 1.5% CD.34. cclls (Fig 2c, lane 1) . Similar mcasurements were performed using the CD34'CD22-and CD34'CD22' cells from patient 6 (data not shown). In this case, thc CD34'CD22' subpopulations was larger than the CD34'CD20' subpopulation and contained the latter. CDW mRNA was detected in the CD34'CD22-cells with the immature phenotype but not in the CD34'CD22' cells. The low levels of CD34 mRNA in the CD34' B-prccursor ALL cells that also have the CD20 and CD22 antigens on their surfacc indicate either a marked reduction or a cessation of the synthesis of the CD34 molecule in this subpopulation. Whether the low levels of CD34 mRNA in the cclls with the more mature phenotype arc due to the lack of gene transcription or to posttranscriptional regulation of the message was not determined.
The results described in the previous paragraph demonstrate that the presence of the CD34 antigen on the cell surface is not a reliable measure of ongoing intracellular synthesis. To further establish whether CD34 mRNA can be used to measure the extent of differentiation in this leukemia, we determined these mRNA levels in CD34+ and CD34-subpopulations isolated from the fresh bone marrow specimens of patients 3 through 5. The result of Northem blot hybridization of RNA from the cclls of patient 3 with thc CD34 probe (Fig 3) is representative of the results obtained for these three cases. CD34 mRNA was detected in the CD34' cells (lane 3) but not in an equal amount of RNA isolated from the CD-34-cells (lane 4). These data suggest that CD34 gene transcription is a uscful measure of differentiation in these leukemia cell populations. Furthermore, they confirm that the CD34 message has a lifetime of sufficient duration to allow its detection in Fig 1) .
B-precursor ALL cells after they arc separated into subpopulations. c-myb mRNA i s limited to subpopulations containing CD34 mMA. Because the c-myh nuclear oncogene is expressed in primitive hematopoietic cells, including early B cells, it could also bc prcscnt in the ALL cells with the Beell progenitor immunophenotypcu3 This possibility was examined by rchybridizing the nitrocellulose filters with a c-myb cDNA probe. Figurc 2d shows that the c-myb message was detected only in the RNA isolated from CD34' cclls of patient 7 that did not express CD20. The c-myb mRNA was also found only in the cells with precursor immunophenotype from patients 3 and 6. No c-myb message was detected in the leukemia cells of patients 4 and 5 (data not shown). Thus, when the c-myh gene expression was detected it was limited to those cells that also expressed CD34 mRNA.
DISCUSSION
The results presented here are consistent with the presence of a differentiation program in untreated B-precursor ALL that is characterized by the sequential appearance of Bcell differentiation antigens in a pattern similar to normal devclopment. The kinetics of CD34 gene transcription during normal Beell dcvclopment is unknown, but it is reasonable to assume that transcription is downregulated during the earliest stage, after which the protein is no longer present. We present evidence that the presence of CD34 mRNA is a more precise measure of precursor properties than CD34 surface antigen expression, especially in those cases where virtually all of the leukemia cells are CD34'. The simultaneous appearance of the CD34 antigen and an antigen that appears much later in normal differentiation, eg, CD20 or CD22, is common in B-precursor ALL and has been termed "asynchronous expressi~n."~,~ The presence of CD34 mRNA only in cells that lack surface expression of the later differentiation antigen indicates that "asynchronous expression" is the result of the persistence of the CD34 molecule on the cell surface rather than the simultaneous synthesis of the two antigens. This conclusion is consistent with the results of other studies that examined the behavior of the CD34 antigen in KG1 and KGla cell^.**^^^ Thus, the appearance of cell surface markers on leukemia cells in a pattern that deviates from normal development is not the result of grossly deranged gene expression.
A demonstrable pattern of differentiation in leukemia implies, by analogy with other developing biologic systems, the presence of a progenitor cell population with in vivo self-renewal capability. Because this group of progenitor cells is likely to sustain the disease and produce relapse when therapy fails, it is self-evident that cure requires its elimination. The identification of the immunophenotypic subpopulation that contains these cells could have immediate application to the detection of residual leukemia using either the polymerase chain reaction or the in vitro ALL blast colony assay.w331 Restriction of the detection procedure to cells in the immunophenotypic subpopulation containing the most primitive leukemia cells would improve the reliability of interpretation. Furthermore, if the proportion of leukemia cells in this subpopulation is increased relative to all marrow cells, then the increased signal-tobackground ratio would improve the chances of detecting residual leukemia. This could be especially important if the only remaining leukemia cells were precursors in a quiescent state.
The ability to define the general features of a maturation process using known reagents provides the motivation to identify and characterize the earliest leukemia progenitors. Ultimately, this identification could lead to the identification of those regulatory genes associated with leukemogenesis and allow treatment based on properties unique to these cells.
